% alzhub.org library filter
% Source: https://alzhub.org/research?score_min=67&atag=memantine
% 89 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{banerjee2021-34688369,
  author  = {Banerjee, Sube and High, Juliet and Stirling, Susan and Shepstone, Lee and Swart, Ann Marie and Telling, Tanya and Henderson, Catherine and Ballard, Clive and others},
  title   = {{Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial}},
  journal = {Lancet (London, England)},
  year    = {2021},
  doi     = {10.1016/s0140-6736(21)01210-1},
  pmid    = {34688369},
  url     = {https://doi.org/10.1016/s0140-6736(21)01210-1}
}

@article{vijverberg2026-41930592,
  author  = {Vijverberg, Everard G B and Scharre, Douglas W and Woodward, Michael and Catalano, Susan and Hamby, Mary E and Grundman, Michael and Morgan, Roger E and Iaci, Jennifer and others},
  title   = {{Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2026},
  doi     = {10.1177/13872877261437145},
  pmid    = {41930592},
  url     = {https://doi.org/10.1177/13872877261437145}
}

@article{holper2026-41980907,
  author  = {Holper, Sarah and Barnham, Kevin J and Churilov, Leonid and Yates, Paul and Brodtmann, Amy and Johns, Sally and Li, Qia-Xin and Bhalala, Oneil and others},
  title   = {{A phase 2, randomized, multicenter, double-blind, placebo-controlled trial of S-adenosyl methionine in participants with mild cognitive impairment or dementia due to Alzheimer's disease}},
  journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association},
  year    = {2026},
  doi     = {10.1002/alz.71381},
  pmid    = {41980907},
  url     = {https://doi.org/10.1002/alz.71381}
}

@article{burns2021-34146512,
  author  = {Burns, Daniel K and Alexander, Robert C and Welsh-Bohmer, Kathleen A and Culp, Meredith and Chiang, Carl and O'Neil, Janet and Evans, Rebecca M and Harrigan, Patrick and others},
  title   = {{Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial}},
  journal = {The Lancet. Neurology},
  year    = {2021},
  doi     = {10.1016/s1474-4422(21)00043-0},
  pmid    = {34146512},
  url     = {https://doi.org/10.1016/s1474-4422(21)00043-0}
}

@article{macfarlane2025-39800452,
  author  = {Macfarlane, S. and Grimmer, T. and Teo, K. and O'Brien, T. J. and Woodward, M. and Grunfeld, J. and Mander, A. and Brodtmann, A. and others},
  title   = {{Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2024.100016},
  pmid    = {39800452},
  url     = {https://doi.org/10.1016/j.tjpad.2024.100016}
}

@article{mehta2017-28832937,
  author  = {Mehta, Nishila and Rodrigues, Craig and Lamba, Manpreet and Wu, Wei and Bronskill, Susan E and Herrmann, Nathan and Gill, Sudeep S and Chan, An-Wen and others},
  title   = {{Systematic Review of Sex-Specific Reporting of Data: Cholinesterase Inhibitor Example}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2017},
  doi     = {10.1111/jgs.15020},
  pmid    = {28832937},
  url     = {https://doi.org/10.1111/jgs.15020}
}

@article{matsunaga2015-25860130,
  author  = {Matsunaga, S. and Kishi, T. and Iwata, N.},
  title   = {{Memantine monotherapy for Alzheimer's disease: a systematic review and meta-analysis}},
  journal = {PloS one},
  year    = {2015},
  doi     = {10.1371/journal.pone.0123289},
  pmid    = {25860130},
  url     = {https://doi.org/10.1371/journal.pone.0123289}
}

@article{winblad2008-18322263,
  author  = {Winblad, B. and Gauthier, S. and Scinto, L. and Feldman, H. and Wilcock, G. K. and Truyen, L. and Mayorga, A. J. and Wang, D. and others},
  title   = {{Safety and efficacy of galantamine in subjects with mild cognitive impairment}},
  journal = {Neurology},
  year    = {2008},
  doi     = {10.1212/01.wnl.0000303815.69777.26},
  pmid    = {18322263},
  url     = {https://doi.org/10.1212/01.wnl.0000303815.69777.26}
}

@article{terao2024-38253184,
  author  = {Terao, Itsuki and Kodama, Wakako},
  title   = {{Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis}},
  journal = {Ageing research reviews},
  year    = {2024},
  doi     = {10.1016/j.arr.2024.102203},
  pmid    = {38253184},
  url     = {https://doi.org/10.1016/j.arr.2024.102203}
}

@article{deng2024-39312316,
  author  = {Deng, Xiaoyan and Li, Daishun},
  title   = {{Effect of long-term pharmacological treatments on Alzheimer disease: A systematic review and network meta-analysis}},
  journal = {Medicine},
  year    = {2024},
  doi     = {10.1097/md.0000000000039753},
  pmid    = {39312316},
  url     = {https://doi.org/10.1097/md.0000000000039753}
}

@article{hannestad2021-33967047,
  author  = {Hannestad, Jonas and Duclos, Tiffanie and Chao, Whitney and Koborsi, Katie and Klutzaritz, Vicki and Beck, Brian and Patel, Ashok K and Scott, James and others},
  title   = {{Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2021},
  doi     = {10.3233/jad-210011},
  pmid    = {33967047},
  url     = {https://doi.org/10.3233/jad-210011}
}

@article{costa2022-34942135,
  author  = {Costa, Alberto C S and Brandão, Ana C and Boada, Richard and Barrionuevo, Veridiana L and Taylor, Hudson G and Roth, Elizabeth and Stasko, Melissa R and Johnson, Mark W and others},
  title   = {{Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial}},
  journal = {The Lancet. Neurology},
  year    = {2022},
  doi     = {10.1016/s1474-4422(21)00369-0},
  pmid    = {34942135},
  url     = {https://doi.org/10.1016/s1474-4422(21)00369-0}
}

@article{winblad2001-11502918,
  author  = {Winblad, B. and Engedal, K. and Soininen, H. and Verhey, F. and Waldemar, G. and Wimo, A. and Wetterholm, A. L. and Zhang, R. and others},
  title   = {{A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD}},
  journal = {Neurology},
  year    = {2001},
  doi     = {10.1212/wnl.57.3.489},
  pmid    = {11502918},
  url     = {https://doi.org/10.1212/wnl.57.3.489}
}

@article{greeley2025-40912996,
  author  = {Greeley, David and Nash, Marshall and Herskowitz, Brad and Kim, Fred and Rock, James and Prins, Neils and Kim, SangYun and Xi, Tianyang and others},
  title   = {{A phase 2 randomized, placebo-controlled study on the efficacy and safety of AR1001, a phosphodiesterase-5 inhibitor, in patients with mild-to-moderate Alzheimer's disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2025},
  doi     = {10.1016/j.tjpad.2025.100337},
  pmid    = {40912996},
  url     = {https://doi.org/10.1016/j.tjpad.2025.100337}
}

@article{rosenbloom2021-33719017,
  author  = {Rosenbloom, Michael and Barclay, Terry R and Kashyap, Bhavani and Hage, Lyndsay and O'Keefe, Lauren R and Svitak, Aleta and Pyle, Maria and Frey, William and others},
  title   = {{A Phase II, Single-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Therapeutic Efficacy of Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease}},
  journal = {Drugs \& aging},
  year    = {2021},
  doi     = {10.1007/s40266-021-00845-7},
  pmid    = {33719017},
  url     = {https://doi.org/10.1007/s40266-021-00845-7}
}

@article{wilkinson2014-25297016,
  author  = {Wilkinson, David and Windfeld, Kristian and Colding-Jørgensen, Eskild},
  title   = {{Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial}},
  journal = {The Lancet. Neurology},
  year    = {2014},
  doi     = {10.1016/s1474-4422(14)70198-x},
  pmid    = {25297016},
  url     = {https://doi.org/10.1016/s1474-4422(14)70198-x}
}

@article{knapp1994-8139083,
  author  = {Knapp, M. J. and Knopman, D. S. and Solomon, P. R. and Pendlebury, W. W. and Davis, C. S. and Gracon, S. I.},
  title   = {{A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group}},
  journal = {JAMA},
  year    = {1994},
  doi     = {10.1001/jama.1994.03510370037029},
  pmid    = {8139083},
  url     = {https://doi.org/10.1001/jama.1994.03510370037029}
}

@article{hegarty1994-8092334,
  author  = {Hegarty, J. D. and Baldessarini, R. J. and Tohen, M. and Waternaux, C. and Oepen, G.},
  title   = {{One hundred years of schizophrenia: a meta-analysis of the outcome literature}},
  journal = {The American journal of psychiatry},
  year    = {1994},
  doi     = {10.1176/ajp.151.10.1409},
  pmid    = {8092334},
  url     = {https://doi.org/10.1176/ajp.151.10.1409}
}

@article{cas2024-38565814,
  author  = {Cas, A Dei and Micheli, M M and Aldigeri, R and Gardini, S and Ferrari-Pellegrini, F and Perini, M and Messa, G and Antonini, M and others},
  title   = {{Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial}},
  journal = {Journal of endocrinological investigation},
  year    = {2024},
  doi     = {10.1007/s40618-024-02320-7},
  pmid    = {38565814},
  url     = {https://doi.org/10.1007/s40618-024-02320-7}
}

@article{watts2023-35109724,
  author  = {Watts, Katrina E and Storr, Nicholas J and Barr, Phoebe G and Rajkumar, Anto P},
  title   = {{Systematic review of pharmacological interventions for people with Lewy body dementia}},
  journal = {Aging \& mental health},
  year    = {2023},
  doi     = {10.1080/13607863.2022.2032601},
  pmid    = {35109724},
  url     = {https://doi.org/10.1080/13607863.2022.2032601}
}

@article{cury2025-41160460,
  author  = {Cury, Rafael de Morais and da Silva, Taynara and Cezar-Dos-Santos, Fernando and Fakih, Yasmin Rafaela Correia and Narvaez, Karlin Andrea Ramírez and Gouvea, Murilo Chaves and Espínola, Carlos and Ferreira, Charles Francisco and others},
  title   = {{A randomized clinical trial of low-dose cannabis extract in Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2025},
  doi     = {10.1177/13872877251389608},
  pmid    = {41160460},
  url     = {https://doi.org/10.1177/13872877251389608}
}

@article{sauder2022-36414626,
  author  = {Sauder, Colin and Allen, Luke A and Baker, Elizabeth and Miller, Andrew C and Paul, Steven M and Brannan, Stephen K},
  title   = {{Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study}},
  journal = {Translational psychiatry},
  year    = {2022},
  doi     = {10.1038/s41398-022-02254-9},
  pmid    = {36414626},
  url     = {https://doi.org/10.1038/s41398-022-02254-9}
}

@article{takada2022-35932158,
  author  = {Takada, Michihiro and Tanaka, Shin and Tanaka, Koh and Tsukie, Tamao and Tsukamoto-Yasui, Masako and Suzuki, Katsuya and Noguchi, Yasushi and Imaizumi, Akira and others},
  title   = {{Effects of an essential amino acid mixture on behavioral and psychological symptoms of dementia and executive function in patients with Alzheimer's disease: A double-blind, randomized, placebo-controlled exploratory clinical trial}},
  journal = {International journal of geriatric psychiatry},
  year    = {2022},
  doi     = {10.1002/gps.5782},
  pmid    = {35932158},
  url     = {https://doi.org/10.1002/gps.5782}
}

@article{nave2017-28550255,
  author  = {Nave, Stephane and Doody, Rachelle S and Boada, Mercè and Grimmer, Timo and Savola, Juha-Matti and Delmar, Paul and Pauly-Evers, Meike and Nikolcheva, Tania and others},
  title   = {{Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-161309},
  pmid    = {28550255},
  url     = {https://doi.org/10.3233/jad-161309}
}

@article{kavirajan2007-17689146,
  author  = {Kavirajan, H. and Schneider, L. S.},
  title   = {{Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials}},
  journal = {The Lancet. Neurology},
  year    = {2007},
  doi     = {10.1016/s1474-4422(07)70195-3},
  pmid    = {17689146},
  url     = {https://doi.org/10.1016/s1474-4422(07)70195-3}
}

@article{ballard2009-19138567,
  author  = {Ballard, C. and Hanney, M. L. and Theodoulou, M. and Douglas, S. and McShane, R. and Kossakowski, K. and Gill, R. and Juszczak, E. and others},
  title   = {{The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial}},
  journal = {The Lancet. Neurology},
  year    = {2009},
  doi     = {10.1016/s1474-4422(08)70295-3},
  pmid    = {19138567},
  url     = {https://doi.org/10.1016/s1474-4422(08)70295-3}
}

@article{teri2000-11087767,
  author  = {Teri, L. and Logsdon, R. G. and Peskind, E. and Raskind, M. and Weiner, M. F. and Tractenberg, R. E. and Foster, N. L. and Schneider, L. S. and others},
  title   = {{Treatment of agitation in AD: a randomized, placebo-controlled clinical trial}},
  journal = {Neurology},
  year    = {2000},
  doi     = {10.1212/wnl.55.9.1271},
  pmid    = {11087767},
  url     = {https://doi.org/10.1212/wnl.55.9.1271}
}

@article{gill2004-15604527,
  author  = {Gill, S. S. and Bronskill, S. E. and Mamdani, M. and Sykora, K. and Li, P. and Shulman, K. I. and Anderson, G. M. and Hillmer, M. P. and others},
  title   = {{Representation of patients with dementia in clinical trials of donepezil}},
  journal = {The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique},
  year    = {2004},
  pmid    = {15604527}
}

@article{bullock2005-16083542,
  author  = {Bullock, Roger and Touchon, Jacques and Bergman, Howard and Gambina, Giuseppe and He, Yunsheng and Rapatz, Günter and Nagel, Jennifer and Lane, Roger},
  title   = {{Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period}},
  journal = {Current medical research and opinion},
  year    = {2005},
  doi     = {10.1185/030079905x56565},
  pmid    = {16083542},
  url     = {https://doi.org/10.1185/030079905x56565}
}

@article{koh2021-33771205,
  author  = {Koh, Seong-Ho and Kwon, Hyuk Sung and Choi, Seong Hye and Jeong, Jee Hyang and Na, Hae Ri and Lee, Chan Nyoung and Yang, YoungSoon and Lee, Ae Young and others},
  title   = {{Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial}},
  journal = {Alzheimer's research \& therapy},
  year    = {2021},
  doi     = {10.1186/s13195-021-00803-w},
  pmid    = {33771205},
  url     = {https://doi.org/10.1186/s13195-021-00803-w}
}

@article{wesnes2005-16301500,
  author  = {Wesnes, K. A. and McKeith, I. and Edgar, C. and Emre, M. and Lane, R.},
  title   = {{Benefits of rivastigmine on attention in dementia associated with Parkinson disease}},
  journal = {Neurology},
  year    = {2005},
  doi     = {10.1212/01.wnl.0000184517.69816.e9},
  pmid    = {16301500},
  url     = {https://doi.org/10.1212/01.wnl.0000184517.69816.e9}
}

@article{holmes2004-15277611,
  author  = {Holmes, C. and Wilkinson, D. and Dean, C. and Vethanayagam, S. and Olivieri, S. and Langley, A. and Pandita-Gunawardena, N. D. and Hogg, F. and others},
  title   = {{The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease}},
  journal = {Neurology},
  year    = {2004},
  doi     = {10.1212/01.wnl.0000129990.32253.7b},
  pmid    = {15277611},
  url     = {https://doi.org/10.1212/01.wnl.0000129990.32253.7b}
}

@article{aisen2000-10680787,
  author  = {Aisen, P. S. and Davis, K. L. and Berg, J. D. and Schafer, K. and Campbell, K. and Thomas, R. G. and Weiner, M. F. and Farlow, M. R. and others},
  title   = {{A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study}},
  journal = {Neurology},
  year    = {2000},
  doi     = {10.1212/wnl.54.3.588},
  pmid    = {10680787},
  url     = {https://doi.org/10.1212/wnl.54.3.588}
}

@article{degiorgi2024-39764175,
  author  = {De Giorgi, Riccardo and Koychev, Ivan and Adler, Amanda I and Cowen, Philip J and Harmer, Catherine J and Harrison, Paul J and Taquet, Maxime},
  title   = {{12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study}},
  journal = {EClinicalMedicine},
  year    = {2024},
  doi     = {10.1016/j.eclinm.2024.102726},
  pmid    = {39764175},
  url     = {https://doi.org/10.1016/j.eclinm.2024.102726}
}

@article{zhou2021-33614900,
  author  = {Zhou, Bo and Zissimopoulos, Julie and Nadeem, Hasan and Crane, Matthew A and Goldman, Dana and Romley, John A},
  title   = {{Association between exenatide use and incidence of Alzheimer's disease}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2021},
  doi     = {10.1002/trc2.12139},
  pmid    = {33614900},
  url     = {https://doi.org/10.1002/trc2.12139}
}

@article{wilkinson2001-11571763,
  author  = {Wilkinson, D and Murray, J},
  title   = {{Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease}},
  journal = {International journal of geriatric psychiatry},
  year    = {2001},
  doi     = {10.1002/gps.409},
  pmid    = {11571763},
  url     = {https://doi.org/10.1002/gps.409}
}

@article{trinh2003-12517232,
  author  = {Trinh, N. H. and Hoblyn, J. and Mohanty, S. and Yaffe, K.},
  title   = {{Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis}},
  journal = {JAMA},
  year    = {2003},
  doi     = {10.1001/jama.289.2.210},
  pmid    = {12517232},
  url     = {https://doi.org/10.1001/jama.289.2.210}
}

@article{kishi2017-28922160,
  author  = {Kishi, T. and Matsunaga, S. and Oya, K. and Nomura, I. and Ikuta, T. and Iwata, N.},
  title   = {{Memantine for Alzheimer's Disease: An Updated Systematic Review and Meta-analysis}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-170424},
  pmid    = {28922160},
  url     = {https://doi.org/10.3233/jad-170424}
}

@article{abushakra2017-29182706,
  author  = {Abushakra, S and Porsteinsson, A and Scheltens, P and Sadowsky, C and Vellas, B and Cummings, J and Gauthier, S and Hey, J A and others},
  title   = {{Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification Potential}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2017},
  doi     = {10.14283/jpad.2017.26},
  pmid    = {29182706},
  url     = {https://doi.org/10.14283/jpad.2017.26}
}

@article{furukawa2017-26711658,
  author  = {Furukawa, Katsutoshi and Tomita, Naoki and Uematsu, Daisuke and Okahara, Kazunori and Shimada, Hiroyuki and Ikeda, Masaki and Matsui, Toshifumi and Kozaki, Koichi and others},
  title   = {{Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease}},
  journal = {Geriatrics \& gerontology international},
  year    = {2017},
  doi     = {10.1111/ggi.12696},
  pmid    = {26711658},
  url     = {https://doi.org/10.1111/ggi.12696}
}

@article{lovestone2015-25537011,
  author  = {Lovestone, S. and Boada, M. and Dubois, B. and Hüll, M. and Rinne, J. O. and Huppertz, H. J. and Calero, M. and Andrés, M. V. and others},
  title   = {{A phase II trial of tideglusib in Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-141959},
  pmid    = {25537011},
  url     = {https://doi.org/10.3233/jad-141959}
}

@article{lannfelt2008-18672400,
  author  = {Lannfelt, L. and Blennow, K. and Zetterberg, H. and Batsman, S. and Ames, D. and Harrison, J. and Masters, C. L. and Targum, S. and others},
  title   = {{Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial}},
  journal = {The Lancet. Neurology},
  year    = {2008},
  doi     = {10.1016/s1474-4422(08)70167-4},
  pmid    = {18672400},
  url     = {https://doi.org/10.1016/s1474-4422(08)70167-4}
}

@article{wang2024-39446320,
  author  = {Wang, Jingya and Antza, Christina and Lee, Wen Hwa and Coker, Jesse and Keane, Pearse A and Denniston, Alastair K and Nirantharakumar, Krishnarajah and Adderley, Nicola J},
  title   = {{Pharmacologic Treatments for Dementia and the Risk of Developing Age-Related Macular Degeneration}},
  journal = {JAMA network open},
  year    = {2024},
  doi     = {10.1001/jamanetworkopen.2024.41166},
  pmid    = {39446320},
  url     = {https://doi.org/10.1001/jamanetworkopen.2024.41166}
}

@article{farlow2019-30530975,
  author  = {Farlow, Martin R and Thompson, Richard E and Wei, Lee-Jen and Tuchman, Alan J and Grenier, Elaine and Crockford, David and Wilke, Susanne and Benison, Jeffrey and others},
  title   = {{A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2019},
  doi     = {10.3233/jad-180759},
  pmid    = {30530975},
  url     = {https://doi.org/10.3233/jad-180759}
}

@article{rockwood1997-9164692,
  author  = {Rockwood, K and Beattie, B L and Eastwood, M R and Feldman, H and Mohr, E and Pryse-Phillips, W and Gauthier, S},
  title   = {{A randomized, controlled trial of linopirdine in the treatment of Alzheimer's disease}},
  journal = {The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques},
  year    = {1997},
  doi     = {10.1017/s031716710002148x},
  pmid    = {9164692},
  url     = {https://doi.org/10.1017/s031716710002148x}
}

@article{rogers1996-8915035,
  author  = {Rogers, S. L. and Friedhoff, L. T.},
  title   = {{The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group}},
  journal = {Dementia (Basel, Switzerland)},
  year    = {1996},
  doi     = {10.1159/000106895},
  pmid    = {8915035},
  url     = {https://doi.org/10.1159/000106895}
}

@article{gold2010-20733306,
  author  = {Gold, M. and Alderton, C. and Zvartau-Hind, M. and Egginton, S. and Saunders, A. M. and Irizarry, M. and Craft, S. and Landreth, G. and others},
  title   = {{Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study}},
  journal = {Dementia and geriatric cognitive disorders},
  year    = {2010},
  doi     = {10.1159/000318845},
  pmid    = {20733306},
  url     = {https://doi.org/10.1159/000318845}
}

@article{lanctot2003-12975222,
  author  = {Lanctôt, K. L. and Herrmann, N. and Yau, K. K. and Khan, L. R. and Liu, B. A. and LouLou, M. M. and Einarson, T. R.},
  title   = {{Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis}},
  journal = {CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
  year    = {2003},
  pmid    = {12975222}
}

@article{winblad2007-17380489,
  author  = {Winblad, B. and Cummings, J. and Andreasen, N. and Grossberg, G. and Onofrj, M. and Sadowsky, C. and Zechner, S. and Nagel, J. and others},
  title   = {{A six-month double-blind, randomized, placebo-controlled study of a transdermal patch in Alzheimer's disease--rivastigmine patch versus capsule}},
  journal = {International journal of geriatric psychiatry},
  year    = {2007},
  doi     = {10.1002/gps.1788},
  pmid    = {17380489},
  url     = {https://doi.org/10.1002/gps.1788}
}

@article{howard2007-17914039,
  author  = {Howard, R. J. and Juszczak, E. and Ballard, C. G. and Bentham, P. and Brown, R. G. and Bullock, R. and Burns, A. S. and Holmes, C. and others},
  title   = {{Donepezil for the treatment of agitation in Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2007},
  doi     = {10.1056/nejmoa066583},
  pmid    = {17914039},
  url     = {https://doi.org/10.1056/nejmoa066583}
}

@article{masurkar2022-34854475,
  author  = {Masurkar, Prajakta P and Chatterjee, Satabdi and Sherer, Jeffrey T and Chen, Hua and Johnson, Michael L and Aparasu, Rajender R},
  title   = {{Risk of overactive bladder associated with cholinesterase inhibitors in dementia}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2022},
  doi     = {10.1111/jgs.17579},
  pmid    = {34854475},
  url     = {https://doi.org/10.1111/jgs.17579}
}

@article{masurkar2021-34027602,
  author  = {Masurkar, Prajakta P and Chatterjee, Satabdi and Sherer, Jeffrey T and Aparasu, Rajender R},
  title   = {{Antimuscarinic Cascade Across Individual Cholinesterase Inhibitors in Older Adults with Dementia}},
  journal = {Drugs \& aging},
  year    = {2021},
  doi     = {10.1007/s40266-021-00863-5},
  pmid    = {34027602},
  url     = {https://doi.org/10.1007/s40266-021-00863-5}
}

@article{rege2021-33763822,
  author  = {Rege, Sanika and Carnahan, Ryan M and Johnson, Michael L and Chen, Hua and Holmes, Holly M and Aparasu, Rajender R},
  title   = {{Antipsychotic Initiation Among Older Dementia Patients Using Cholinesterase Inhibitors: A National Retrospective Cohort Study}},
  journal = {Drugs \& aging},
  year    = {2021},
  doi     = {10.1007/s40266-021-00851-9},
  pmid    = {33763822},
  url     = {https://doi.org/10.1007/s40266-021-00851-9}
}

@article{wolters1990-2192301,
  author  = {Wolters, E C and Riekkinen, P and Lowenthal, A and Van der Plaats, J J and Zwart, J M and Sennef, C},
  title   = {{DGAVP (Org 5667) in early Alzheimer's disease patients: an international double-blind, placebo-controlled, multicenter trial}},
  journal = {Neurology},
  year    = {1990},
  doi     = {10.1212/wnl.40.7.1099},
  pmid    = {2192301},
  url     = {https://doi.org/10.1212/wnl.40.7.1099}
}

@article{tian2023-37302139,
  author  = {Tian, S. and Jiang, J. and Wang, J. and Zhang, Z. and Miao, Y. and Ji, X. and Bi, Y.},
  title   = {{Comparison on cognitive outcomes of antidiabetic agents for type 2 diabetes: A systematic review and network meta-analysis}},
  journal = {Diabetes/metabolism research and reviews},
  year    = {2023},
  doi     = {10.1002/dmrr.3673},
  pmid    = {37302139},
  url     = {https://doi.org/10.1002/dmrr.3673}
}

@article{winblad2006-16581404,
  author  = {Winblad, B. and Kilander, L. and Eriksson, S. and Minthon, L. and Båtsman, S. and Wetterholm, A. L. and Jansson-Blixt, C. and Haglund, A. and others},
  title   = {{Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study}},
  journal = {Lancet (London, England)},
  year    = {2006},
  doi     = {10.1016/s0140-6736(06)68350-5},
  pmid    = {16581404},
  url     = {https://doi.org/10.1016/s0140-6736(06)68350-5}
}

@article{walker1996-9038610,
  author  = {Walker, L. G. and Wesnes, K. P. and Heys, S. D. and Walker, M. B. and Lolley, J. and Eremin, O.},
  title   = {{The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments}},
  journal = {European journal of cancer (Oxford, England : 1990)},
  year    = {1996},
  doi     = {10.1016/s0959-8049(96)00300-0},
  pmid    = {9038610},
  url     = {https://doi.org/10.1016/s0959-8049(96)00300-0}
}

@article{delser2013-22936007,
  author  = {del Ser, T. and Steinwachs, K. C. and Gertz, H. J. and Andrés, M. V. and Gómez-Carrillo, B. and Medina, M. and Vericat, J. A. and Redondo, P. and others},
  title   = {{Treatment of Alzheimer's disease with the GSK-3 inhibitor tideglusib: a pilot study}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2013},
  doi     = {10.3233/jad-2012-120805},
  pmid    = {22936007},
  url     = {https://doi.org/10.3233/jad-2012-120805}
}

@article{summers1986-2430180,
  author  = {Summers, W. K. and Majovski, L. V. and Marsh, G. M. and Tachiki, K. and Kling, A.},
  title   = {{Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type}},
  journal = {The New England journal of medicine},
  year    = {1986},
  doi     = {10.1056/nejm198611133152001},
  pmid    = {2430180},
  url     = {https://doi.org/10.1056/nejm198611133152001}
}

@article{green2019-30652263,
  author  = {Green, A. R. and Reifler, L. M. and Bayliss, E. A. and Weffald, L. A. and Boyd, C. M.},
  title   = {{Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study}},
  journal = {Drugs \& aging},
  year    = {2019},
  doi     = {10.1007/s40266-018-00630-z},
  pmid    = {30652263},
  url     = {https://doi.org/10.1007/s40266-018-00630-z}
}

@article{ma2024-38592337,
  author  = {Ma, Xiao-Na and Feng, Wei and Chen, Shu-Lin and Zhong, Xiao-Qin and Lin, Chang-Song and Xu, Qiang},
  title   = {{Methotrexate and the Risk of Dementia: A Two-Sample Mendelian Randomization Study}},
  journal = {Neurology and therapy},
  year    = {2024},
  doi     = {10.1007/s40120-024-00609-6},
  pmid    = {38592337},
  url     = {https://doi.org/10.1007/s40120-024-00609-6}
}

@article{chen2024-38640313,
  author  = {Chen, Yan and Lai, Min and Tao, Ming},
  title   = {{Evaluating the efficacy and safety of Alzheimer's disease drugs: A meta-analysis and systematic review}},
  journal = {Medicine},
  year    = {2024},
  doi     = {10.1097/md.0000000000037799},
  pmid    = {38640313},
  url     = {https://doi.org/10.1097/md.0000000000037799}
}

@article{gao2024-38439609,
  author  = {Gao, Yaqi and Liu, Yulin and Li, Yanfang},
  title   = {{Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis}},
  journal = {Advances in clinical and experimental medicine : official organ Wroclaw Medical University},
  year    = {2024},
  doi     = {10.17219/acem/176051},
  pmid    = {38439609},
  url     = {https://doi.org/10.17219/acem/176051}
}

@article{carney2019-31921965,
  author  = {Carney, Greg and Bassett, Ken and Wright, James M and Maclure, Malcolm and McGuire, Nicolette and Dormuth, Colin R},
  title   = {{Comparison of cholinesterase inhibitor safety in real-world practice}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2019},
  doi     = {10.1016/j.trci.2019.09.011},
  pmid    = {31921965},
  url     = {https://doi.org/10.1016/j.trci.2019.09.011}
}

@article{abouelmagd2025-41188985,
  author  = {Abouelmagd, Moaz Elsayed and Almosilhy, Nereen A and Makhlouf, Hamdy A and Hassan, Amr K and Osman, Ahmed S A and Hindawi, Mahmoud Diaa and Elshahat, Ahmed and Alnajjar, Asmaa Zakria and others},
  title   = {{Comparative safety of cholinesterase inhibitors and memantine for dementia: a protocol for a network meta-analysis of randomized controlled trials}},
  journal = {Systematic reviews},
  year    = {2025},
  doi     = {10.1186/s13643-025-02961-6},
  pmid    = {41188985},
  url     = {https://doi.org/10.1186/s13643-025-02961-6}
}

@article{bhattacharjee2019-31338414,
  author  = {Bhattacharjee, Sandipan and Patanwala, Asad E and Lo-Ciganic, Wei-Hsuan and Malone, Daniel C and Lee, Jeannie K and Knapp, Shannon M and Warholak, Terri and Burke, William J},
  title   = {{Alzheimer's disease medication and risk of all-cause mortality and all-cause hospitalization: A retrospective cohort study}},
  journal = {Alzheimer's \& dementia (New York, N. Y.)},
  year    = {2019},
  doi     = {10.1016/j.trci.2019.05.005},
  pmid    = {31338414},
  url     = {https://doi.org/10.1016/j.trci.2019.05.005}
}

@article{sheehan2015-26330451,
  author  = {Sheehan, Rory and Hassiotis, Angela and Walters, Kate R and Osborn, David and Strydom, André and Horsfall, Laura},
  title   = {{Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study}},
  journal = {BMJ},
  year    = {2015},
  doi     = {10.1136/bmj.h4326},
  pmid    = {26330451},
  url     = {https://doi.org/10.1136/bmj.h4326}
}

@article{doody2008-18640457,
  author  = {Doody, R. S. and Gavrilova, S. I. and Sano, M. and Thomas, R. G. and Aisen, P. S. and Bachurin, S. O. and Seely, L. and Hung, D. and others},
  title   = {{Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study}},
  journal = {Lancet (London, England)},
  year    = {2008},
  doi     = {10.1016/s0140-6736(08)61074-0},
  pmid    = {18640457},
  url     = {https://doi.org/10.1016/s0140-6736(08)61074-0}
}

@article{pozzi2022-36203811,
  author  = {Pozzi, Federico Emanuele and Conti, Elisa and Appollonio, Ildebrando and Ferrarese, Carlo and Tremolizzo, Lucio},
  title   = {{Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review}},
  journal = {Frontiers in neuroscience},
  year    = {2022},
  doi     = {10.3389/fnins.2022.998224},
  pmid    = {36203811},
  url     = {https://doi.org/10.3389/fnins.2022.998224}
}

@article{ioakeimskoufa2023-37296934,
  author  = {Ioakeim-Skoufa, Ignatios and Tobajas-Ramos, Natalia and Menditto, Enrica and Aza-Pascual-Salcedo, Mercedes and Gimeno-Miguel, Antonio and Orlando, Valentina and González-Rubio, Francisca and Fanlo-Villacampa, Ana and others},
  title   = {{Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials}},
  journal = {Cancers},
  year    = {2023},
  doi     = {10.3390/cancers15112972},
  pmid    = {37296934},
  url     = {https://doi.org/10.3390/cancers15112972}
}

@article{alexander2022-36245899,
  author  = {Alexander, Peter and Visagan, Shakthi and Jawhar, Sara and Kare, Amogh and Issa, Noor and Issa, Reem and Jawhar, Abbas and Thomas, Sneha and others},
  title   = {{Antiplatelets and Vascular Dementia: A Systematic Review}},
  journal = {Journal of aging research},
  year    = {2022},
  doi     = {10.1155/2022/9780067},
  pmid    = {36245899},
  url     = {https://doi.org/10.1155/2022/9780067}
}

@article{hey2025-39907966,
  author  = {Hey, J. A. and Yu, J. Y. and Abushakra, S. and Schaefer, J. F. and Power, A. and Kesslak, P. and Paul, J. and Tolar, M.},
  title   = {{Clinical Pharmacokinetics of Oral ALZ-801/Valiltramiprosate in a 2-Year Phase 2 Trial of APOE4 Carriers with Early Alzheimer's Disease}},
  journal = {Clinical pharmacokinetics},
  year    = {2025},
  doi     = {10.1007/s40262-025-01482-8},
  pmid    = {39907966},
  url     = {https://doi.org/10.1007/s40262-025-01482-8}
}

@article{courtney2004-15220031,
  author  = {Courtney, C. and Farrell, D. and Gray, R. and Hills, R. and Lynch, L. and Sellwood, E. and Edwards, S. and Hardyman, W. and others},
  title   = {{Long-term donepezil treatment in 565 patients with Alzheimer's disease (AD2000): randomised double-blind trial}},
  journal = {Lancet (London, England)},
  year    = {2004},
  doi     = {10.1016/s0140-6736(04)16499-4},
  pmid    = {15220031},
  url     = {https://doi.org/10.1016/s0140-6736(04)16499-4}
}

@article{winblad1999-10885864,
  author  = {Winblad, B. and Poritis, N.},
  title   = {{Memantine in severe dementia: results of the 9M-Best Study (Benefit and efficacy in severely demented patients during treatment with memantine)}},
  journal = {International journal of geriatric psychiatry},
  year    = {1999},
  doi     = {10.1002/(sici)1099-1166(199902)14:2<135::aid-gps906>3.0.co;2-0},
  pmid    = {10885864},
  url     = {https://doi.org/10.1002/(sici)1099-1166(199902)14:2<135::aid-gps906>3.0.co;2-0}
}

@article{islam2016-28013304,
  author  = {Islam, M. M. and Iqbal, U. and Walther, B. and Atique, S. and Dubey, N. K. and Nguyen, P. A. and Poly, T. N. and Masud, J. H. and others},
  title   = {{Benzodiazepine Use and Risk of Dementia in the Elderly Population: A Systematic Review and Meta-Analysis}},
  journal = {Neuroepidemiology},
  year    = {2016},
  doi     = {10.1159/000454881},
  pmid    = {28013304},
  url     = {https://doi.org/10.1159/000454881}
}

@article{schneider2006-17035647,
  author  = {Schneider, L. S. and Tariot, P. N. and Dagerman, K. S. and Davis, S. M. and Hsiao, J. K. and Ismail, M. S. and Lebowitz, B. D. and Lyketsos, C. G. and others},
  title   = {{Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2006},
  doi     = {10.1056/nejmoa061240},
  pmid    = {17035647},
  url     = {https://doi.org/10.1056/nejmoa061240}
}

@article{farlow1992-1404819,
  author  = {Farlow, M. and Gracon, S. I. and Hershey, L. A. and Lewis, K. W. and Sadowsky, C. H. and Dolan-Ureno, J.},
  title   = {{A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group}},
  journal = {JAMA},
  year    = {1992},
  doi     = {10.1001/jama.1992.03490180055026},
  pmid    = {1404819},
  url     = {https://doi.org/10.1001/jama.1992.03490180055026}
}

@article{bronskill2004-15086656,
  author  = {Bronskill, S. E. and Anderson, G. M. and Sykora, K. and Wodchis, W. P. and Gill, S. and Shulman, K. I. and Rochon, P. A.},
  title   = {{Neuroleptic drug therapy in older adults newly admitted to nursing homes: incidence, dose, and specialist contact}},
  journal = {Journal of the American Geriatrics Society},
  year    = {2004},
  doi     = {10.1111/j.1532-5415.2004.52212.x},
  pmid    = {15086656},
  url     = {https://doi.org/10.1111/j.1532-5415.2004.52212.x}
}

@article{ebrahem2018-29999427,
  author  = {Ebrahem, Anees Shajhan and Oremus, Mark},
  title   = {{A pharmacoeconomic evaluation of cholinesterase inhibitors and memantine for the treatment of Alzheimer's disease}},
  journal = {Expert opinion on pharmacotherapy},
  year    = {2018},
  doi     = {10.1080/14656566.2018.1499727},
  pmid    = {29999427},
  url     = {https://doi.org/10.1080/14656566.2018.1499727}
}

@article{glynnservedio2017-28855009,
  author  = {Glynn-Servedio, Brianna E and Ranola, Trisha Seys},
  title   = {{AChE Inhibitors and NMDA Receptor Antagonists in Advanced Alzheimer's Disease}},
  journal = {The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists},
  year    = {2017},
  doi     = {10.4140/tcp.n.2017.511},
  pmid    = {28855009},
  url     = {https://doi.org/10.4140/tcp.n.2017.511}
}

@article{matsunaga2018-30222469,
  author  = {Matsunaga, Shinji and Kishi, Taro and Nomura, Ikuo and Sakuma, Kenji and Okuya, Makoto and Ikuta, Toshikazu and Iwata, Nakao},
  title   = {{The efficacy and safety of memantine for the treatment of Alzheimer's disease}},
  journal = {Expert opinion on drug safety},
  year    = {2018},
  doi     = {10.1080/14740338.2018.1524870},
  pmid    = {30222469},
  url     = {https://doi.org/10.1080/14740338.2018.1524870}
}

@article{haussmann2017-27822591,
  author  = {Haussmann, R and Donix, M},
  title   = {{[Memantine as add-on medication to acetylcholinesterase inhibitor therapy for Alzheimer dementia]}},
  journal = {Der Nervenarzt},
  year    = {2017},
  doi     = {10.1007/s00115-016-0237-3},
  pmid    = {27822591},
  url     = {https://doi.org/10.1007/s00115-016-0237-3}
}

@article{fleet2019-31527187,
  author  = {Fleet, Jamie L and McArthur, Eric and Patel, Aakil and Weir, Matthew A and Montero-Odasso, Manuel and Garg, Amit X},
  title   = {{Risk of rhabdomyolysis with donepezil compared with rivastigmine or galantamine: a population-based cohort study}},
  journal = {CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
  year    = {2019},
  doi     = {10.1503/cmaj.190337},
  pmid    = {31527187},
  url     = {https://doi.org/10.1503/cmaj.190337}
}

@article{wessels2018-29616706,
  author  = {Wessels, A M and Andersen, S W and Dowsett, S A and Siemers, E R},
  title   = {{The Integrated Alzheimer's Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2018},
  doi     = {10.14283/jpad.2018.10},
  pmid    = {29616706},
  url     = {https://doi.org/10.14283/jpad.2018.10}
}

@article{howard2012-22397651,
  author  = {Howard, R. and McShane, R. and Lindesay, J. and Ritchie, C. and Baldwin, A. and Barber, R. and Burns, A. and Dening, T. and others},
  title   = {{Donepezil and memantine for moderate-to-severe Alzheimer's disease}},
  journal = {The New England journal of medicine},
  year    = {2012},
  doi     = {10.1056/nejmoa1106668},
  pmid    = {22397651},
  url     = {https://doi.org/10.1056/nejmoa1106668}
}

@article{kaduszkiewicz2005-16081444,
  author  = {Kaduszkiewicz, H. and Zimmermann, T. and Beck-Bornholdt, H. P. and van den Bussche, H.},
  title   = {{Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials}},
  journal = {BMJ (Clinical research ed.)},
  year    = {2005},
  doi     = {10.1136/bmj.331.7512.321},
  pmid    = {16081444},
  url     = {https://doi.org/10.1136/bmj.331.7512.321}
}

@article{chou2017-28254448,
  author  = {Chou, P. S. and Ho, B. L. and Yang, Y. H.},
  title   = {{Effects of pioglitazone on the incidence of dementia in patients with diabetes}},
  journal = {Journal of diabetes and its complications},
  year    = {2017},
  doi     = {10.1016/j.jdiacomp.2017.01.006},
  pmid    = {28254448},
  url     = {https://doi.org/10.1016/j.jdiacomp.2017.01.006}
}

@article{shekelle2001-11601948,
  author  = {Shekelle, Paul and MacLean, Catherine H. and Morton, Sally C. and Wenger, Neil S.},
  title   = {{ACOVE Quality Indicators}},
  journal = {Annals of Internal Medicine},
  year    = {2001},
  doi     = {10.7326/0003-4819-135-8_part_2-200110161-00004},
  pmid    = {11601948},
  url     = {https://doi.org/10.7326/0003-4819-135-8_part_2-200110161-00004}
}

@article{kales2011-22193526,
  author  = {Kales, Helen C. and Kim, Hyungjin Myra and Zivin, Kara and Valenstein, Marcia M. and Seyfried, Lisa S. and Chiang, Claire and Cunningham, Francesca E. and Schneider, Lon S. S. and others},
  title   = {{Risk of Mortality Among Individual Antipsychotics in Patients With Dementia}},
  journal = {American Journal of Psychiatry},
  year    = {2011},
  doi     = {10.1176/appi.ajp.2011.11030347},
  pmid    = {22193526},
  url     = {https://doi.org/10.1176/appi.ajp.2011.11030347}
}